• Blog
  • HIV Diagnosis Market Growth Analysis | 2023-2028

    HIV Diagnosis Market Growth Analysis | 2023-2028

    HIV Diagnosis Market Growth Analysis | 2023-2028
    Report code - SRHL243 Delivery - 2 Weeks
    HIV Diagnosis Market Size, Share, Trends, Dynamics, Forecast, Competitive Analysis, and Gr See more...

    Market Insights

    The HIV Diagnosis Market was estimated at US$ 3.73 billion in 2022 and is likely to grow at an exceptional CAGR of 9.12% during 2023-2028 to reach US$ 6.30 billion in 2028.

    HIV Diagnosis Market Size

    Wish to Get a Free Sample? Register Here.

    What is HIV Diagnosis?

    Diagnosis of a blood sample to check the presence of HIV (Human Immunodeficiency Virus) in humans is regarded as an HIV diagnosis. The diagnosis of HIV helps to detect the presence of HIV that causes AIDS (Acquired Immunodeficiency Syndrome). This is carried out by conducting tests on saliva, serum, or urine samples. These tests can detect antigens, antibodies, or RNA.

    HIV Diagnosis Market Highlights

    Market Size in 2022

    US$ 3.73 Billion

    Market Size in 2028

    US$ 6.30 Billion

    Market Growth by 2023-2028

    CAGR of 9.12%

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Dominant Region

    North America held the highest market.

    Key Players

    Some of the major players in the market are-

    • Abbott (The U.S.)
    • Apogee Flow Systems Ltd. (UK)
    • Atomo Diagnostics (Australia)
    • BD Biosciences (The U.S.)
    • Beckman Coulter Inc. (The U.S.)
    • BioMerieux SA (France)
    • Cepheid (The U.S.)
    • ChemBio Diagnostics Inc. (The U.S.)
    • Daktari Diagnostics, Inc. (The U.S.)
    • Hologic Inc. (The U.S.)

    Market Drivers

    The market is expected to grow in the coming years due to several factors, including:

    • Rising incidence of HIV: The increasing prevalence of HIV/AIDS globally is expected to drive the demand for HIV diagnosis tests.
    • Government initiatives: Governments around the world are investing heavily in programs to control the spread of HIV/AIDS, including increased access to testing and treatment. This is likely to increase the demand for HIV diagnosis tests.
    • Technological advancements: The development of new diagnostic tests with high accuracy and sensitivity is expected to boost the demand for HIV diagnosis tests.
    • Growing awareness: Increased awareness about the importance of early detection and treatment of HIV/AIDS is likely to drive the demand for HIV diagnosis tests.
    • The rising number of blood donations & blood transfusions that cause infections is likely to drive the demand for HIV diagnosis tests.
    • Recent advancements of simple rapid assays with visual testing coupled with easy-handling home sample collection methods offer lucrative opportunities to the industry players.

    HIV Diagnosis Market Snapshot

    Get the full scope of the report. Register Here.

    Makret Segmentation

    Test Type Trends

    The market is segmented into antibody tests, viral identification assays, CD4 testing, viral load testing, and early infant diagnosis. Among these, the Antibody Tests Segment accounted for the largest market share and is likely to register a healthy CAGR during the forecast timeline. This is mainly ascribed to the increasing awareness about HIV, rising technological advancements in HIV diagnosis, and growing blood donations, thereby bolstering segment growth.

    Regional Trends

    The North American market held the highest market share and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to the presence of a technologically advanced healthcare framework, supportive reimbursement policies, relatively higher healthcare expenditure in research and development, and the high prevalence of HIV thereby proliferating the industry growth in the region.

    HIV-Diagnosis-Market-Regional-Analysis

    To know which region offers the best growth opportunities, Click Here.

    Market Segmentation

    The market is segmented into the following categories:

    By Product Type

    • Consumables
    • Assay
    • Kits and Reagents
    • Instruments
    • Software
    • Services
    • Other Consumables

    By Test Type

    • Antibody tests
      • Hiv-1 Screening Tests (Elisa, Rapid Tests, Home Access Dried Blood Spot)
      • Hiv-1 Confirmatory Tests (Western Blot Tests, Indirect Immune Fluorescent Antibody Assays (IFA), Line Immunoassays (LIA), Radio-Immunoprecipitation Assays (RIPA))
      • Hiv-2 & Group O Diagnostic Tests
    • Viral Identification Assays
    • CD4 Testing
    • Viral Load Testing
    • Early Infant Diagnosis

    By Application Type

    • Diagnostic Laboratories
    • Hospitals
    • Blood Banks
    • Home care settings
    • Others

    By Region

    • North America (Country Analysis: The USA and the Rest of North America)
    • Europe (Country Analysis: Germany, Italy, Norway, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: Japan, China, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Country Analysis: Latin America and Others)

    HIV-Diagnosis-Market-Segments

    Click Here, to learn the market segmentation details.

    Target Audience

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    Report – Features

    Market Segmentation

    04

    Regions Covered

    04

    Countries/Sub-Regions Covered

    13

    No. of Figures & Tables

    >120

    Company Profiles

    10

     

    The following are the key features of the report:

    • Overview, industry life cycle analysis, supply chain analysis.
    • Environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
    • Trend and forecast analysis.
    • Segment trends and forecast.
    • Competitive landscape and dynamics: Market share, product portfolio, Technology launches, etc.
    • Attractive segments and associated growth opportunities.
    • Emerging trends.
    • Strategic growth opportunities for the existing and new players.
    • Key success factors.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.

    We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Target Audience

    The following is a list of the customers that the market aims to convert the most:

    • Manufacturers
    • Suppliers
    • Distributors
    • Organizations
    • Government bodies

    Customization Option

    Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players).
    • SWOT analysis of key players (up to 3 players).

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research:

    Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Diagnosis of a blood sample to check the presence of HIV (Human Immunodeficiency Virus) in humans is regarded as an HIV diagnosis. The diagnosis of HIV helps to detect the presence of HIV that causes AIDS (Acquired Immunodeficiency Syndrome). This is carried out by conducting tests on saliva, serum, or urine samples. These tests can detect antigens, antibodies, or RNA.

    The HIV diagnosis market was valued at US$ 3.73 billion in 2022 and is likely to reach an annual market size of US$ 6.30 Billion in 2028.

    The market is expected to grow at a CAGR of 9.12% during the forecast period.

    The following are the key players in the HIV diagnosis market - Abbott (The U.S), Apogee Flow Systems Ltd. (UK), Atomo Diagnostics (Australia), BD Biosciences (The U.S), Beckman Coulter Inc. (The U.S), BioMerieux SA (France), Cepheid (The U.S), ChemBio Diagnostics Inc. (The U.S), Daktari Diagnostics, Inc. (The U.S), and Hologic Inc. (The U.S).

    North America held the highest market share in 2022.

    The HIV diagnosis market is expected to grow in the coming years due to several factors, including: Rising incidence of HIV: The increasing prevalence of HIV/AIDS globally is expected to drive the demand for HIV diagnosis tests. Government initiatives: Governments around the world are investing heavily in programs to control the spread of HIV/AIDS, including increased access to testing and treatment. This is likely to increase the demand for HIV diagnosis tests. Technological advancements: The development of new diagnostic tests with high accuracy and sensitivity is expected to boost the demand for HIV diagnosis tests. Growing awareness: Increased awareness about the importance of early detection and treatment of HIV/AIDS is likely to drive the demand for HIV diagnosis tests. The rising number of blood donations & blood transfusions that cause infections is likely to drive the demand for HIV diagnosis tests. Recent advancements of simple rapid assays with visual testing coupled with easy-handling home sample collection methods offer lucrative opportunities to the industry players.